A. D. Darenskaya, B. M. Medvedeva, & A. A. Rumyantsev. (2024). Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: Literature review and a case report. ABV-press.
Chicago Style (17th ed.) CitationA. D. Darenskaya, B. M. Medvedeva, and A. A. Rumyantsev. Combination of Pembrolizumab and Lenvatinib in Second-line Therapy for MSS/pMMR Advanced Endometrial Cancer: Literature Review and a Case Report. ABV-press, 2024.
MLA (9th ed.) CitationA. D. Darenskaya, et al. Combination of Pembrolizumab and Lenvatinib in Second-line Therapy for MSS/pMMR Advanced Endometrial Cancer: Literature Review and a Case Report. ABV-press, 2024.
Warning: These citations may not always be 100% accurate.